
Earlier this year the EU Commission published draft versions of four chapters in its Good Manufacturing Practice (GMP) guide, and …

From Thursday 5 December you will be able to access the digital edition of Pharmafocus on your Apple device via …

Tokyo-based Eisai is to axe 130 jobs in Europe and the US as part of an attempt to shake up …

Merck & Co has said it plans to close down a facility in Ireland with the loss of around 570 …

People will be able to view the quality of dementia care and support in their local area, thanks to a …

Asia’s biggest drugmaker Takeda has named GlaxoSmithKline’s Christophe Weber as the leading candidate for the role of its next chief …

What has happened to the science in clinical research? Well, it is still there, but with the explosion in the …
MHP Communications has announced the appointment of a number of senior and mid-level hires to increase its health practice. Paul …
The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …

UK healthcare group BTG has received approval from the FDA for a new type of varicose vein treatment to be …

GlaxoSmithKline is being accused of using ‘sledgehammer’ tactics by marketing agencies promoting its products after the firm allegedly demanded cash …

Contract research organisation ICON has appointed Manuel Ploch to be its general manager in Japan. Ploch will lead all of …

Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …

In a blow for Pfizer NICE has categorically rejected the manufacturer’s Bosulif as a treatment for previously-treated chronic myeloid leukaemia …

The author of a damning report into failings at the Staffordshire hospital has become the new president of the Patients …

Life science talent management firm PiR Resourcing has appointed industry veteran Perry Evans to be its Client Services director. PiR …

The winners of a £2 million government competition to produce apps which will help combat alcohol abuse and weight gain …

Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …